Neonatal clinical pharmacology: Recent observations of relevance for anaesthesiologists

Acta Anaesthesiologica Belgica

Volumn 59, Issue 4, 2008, Pages 283-288

  Allegaert, Karel ^a   de Hoon, Jan ^a   Naulaers, Gunnar ^a   Van De Velde, Marc ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Developmental pharmacology; Ibuprofen; Newborn; Paracetamol; Propofol; Tramadol

Indexed keywords

ACETYLSALICYLIC ACID; AMIKACIN; CYTOCHROME P450 2D6; IBUPROFEN; INDOMETACIN; O NORTRAMADOL; PARACETAMOL; PROPOFOL; PROSTAGLANDIN SYNTHASE INHIBITOR; TRAMADOL; VANCOMYCIN;

AGE; ANESTHESIST; CLINICAL PHARMACOLOGY; DIURESIS; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG INHIBITION; DRUG METABOLISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TOLERABILITY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; LOADING DRUG DOSE; NEWBORN; NEWBORN CARE; NONHUMAN; OFF LABEL DRUG USE; PATENT DUCTUS ARTERIOSUS; PRESCRIPTION; RECOMMENDED DRUG DOSE; REVIEW; SIDE EFFECT;

ACETAMINOPHEN; AGE FACTORS; ANALGESICS; ANESTHESIOLOGY; BIOLOGICAL AVAILABILITY; CYCLOOXYGENASE INHIBITORS; DRUG LABELING; HUMANS; IBUPROFEN; INFANT, NEWBORN; PAIN; PROPOFOL; TRAMADOL;

EID: 60849099623     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Allegaert K., Anderson B. J., Naulaers G., de Hoon J., Verbesselt R., Debeer A., Devlieger H., Tibboel D., Intravenous paracetamol (propacetamol) pharmaco-kinetics in term and preterm neonates, EUR. J. CLIN. PHARMACOL., 60, 191-197, 2004.
2. Allegaert K., van den Anker J.N., de Hoon J.N., van Schaik R. H., Debeer A., Tibboel D., Naulaers G., Anderson B. J., Covariates of tramadol disposition in the first months of life, BR. J. ANAESTH., 100, 525-532, 2008.
3. Allegaert K., de Hoon J., Verbesselt R., Naulaers G., Murat I., Maturational pharmacokinetics of single intravenous bolus administration of propofol, PAEDIATR. ANESTH., 17, 1028-1034, 2007.
4. Allegaert K., Peeters M. Y., Verbesselt R., Tibboel D., Naulaers G., de Hoon J. N., Knibbe C. A., Interindividual variability in propofol pharmacokinetics in preterm and term neonates, BR. J. ANAESTH., 99, 864-870, 2007.
5. Allegaert K., Rayyan M., Anderson B. J., Impact of ibuprofen administration on renal drug clearance in the first weeks of life, METHODS FIND. EXP. CLIN. PHARMACOL., 28, 519-522, 2006.
6. Allegaert K., Rayyan M., de Rijdt T., van Beek F., Naulaers G., Hepatic tolerance of repeated intravenous paracetamol administration in neonates, PAEDIATR. ANAESTH., 18, 388-392, 2008.
7. Anand K. J., Pharmacological approaches to the management of pain in the neonatal intensive care unit, J. PERINATOL., 27 (S 1), S4-S11, 2007.
8. Anderson B. J., van Lingen R. A., Hansen T. G., Lin Y. C., Holford N. H., Acetaminophen developmental pharmaco-kinetics in premature neonates and infants: A pooled population analysis, ANESTHESIOLOGY , 96, 1336-1345, 2002.
9. Blake M. J., Castro L., Leeder J. S., Kearns G. L., Ontogeny of drug metabolizing enzymes in the neonate, SEMIN. FETAL NEONATAL MED. , 10, 123-138, 2005.
10. Bua J., L'Erario I., Barbi E., Marchetti F., When off-label is a goodpractice: The example of paracetamol and salbutamol, ARCH. DIS. CHILD., 93, 546-547, 2008.
11. Carcillo J. A., Doughty L., Kofos D., Frye R. F., Kaplan S. S., Sasser H., Burckart G. J., Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure, INTENSIVE CARE MED., 29, 980-984, 2003.
12. Choonara I., Improving children's medicines, ARCH. DIS. CHILD. , 91, 550-551, 2006.
13. Guignard J. P., The adverse renal effects of prostaglandin-synthesis inhibitors in the newborn rabbit, SEMIN. PERINATOL., 26, 398-405, 2002.
14. Kearns G. L., Abdel-Rahman S. M., Alander S. W., Blowey D. L., Leeder J. S., Kaufman R. E., Developmental pharmacology: Drug disposition, action, and therapy in infants and children, N. ENGL. J. MED., 349, 1157-1167, 2003.
15. Knibbe C. A., Zuideveld K. P., Aarts L. P., Kuks P. F., Danhof M., Allometric relationships between the pharmacokinetics of propofol in rats, children and adults, BR. J. CLIN. PHARMACOL., 59, 705-711, 2005.
16. Leeder J. S., Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond, DRUG DISCOV. TODAY, 9, 567-573, 2004.
17. Lynn A., Nespeca M. K., Bratton S. L., Strauss S. G., Shen D. D., Clearance of morphine in postoperative infants during intravenous infusion: The influence of age and surgery, ANESTH. ANALG., 86, 958-963, 1998.
18. Rakhmanina N. Y., van den Anker J. N., Pharmacological research in pediatrics: From neonates to adolescents, ADV. DRUG. DELIV. REV. , 58, 4-14, 2006.
19. Tibboel D., Anand K. J., van den Anker J. N., The pharmacological treatment of neonatal pain, SEMIN. FETAL NEONATAL. MED., 10, 195-205, 2005.
20. Van den Anker J., Managing drugs safely, SEMIN. FETAL NEONATAL MED., 10, 73-81, 2005.